Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 44
D Participants Challenges for the Chemical Sciences in the 2ISt Century: Workshop on Health and Medicine William L. Alworth, Tulane University Paul S. Anderson, Bristol-Myers Squibb Company Anand R. Asthagiri, California Institute of Technology John E. Baldwin, Syracuse University Cynthia Bamdad, Minerva Biotechnologies Corporation Georges Belfort, Rensselaer Polytechnic Institute Dale Boger, Scripps Research Institute Ronald Breslow, Columbia University Michael Burkart, University of California, San Diego Cynthia J. Burrows, University of Utah Alison Butler, University of California, Santa Barbara Jeffrey Chalmers, Ohio State University Kevin Chapman, Merck & Co., Inc. Panagiotis D. Christofides, University of California, Los Angeles Steven S. C. Chuang, University of Akron Benjamin F. Cravatt, Scripps Research Institute Samuel Danishefsky, Memorial Sloan-Kettering Cancer Center Nancy A. Da Silva, University of California, Irvine Edward A. Dennis, University of California, San Diego Peter B. Dervan, California Institute of Technology Kenneth M. Doxee, National Science Foundation Christos Georgakis, Polytechnic University Eric M. Gordon, Palantir Consulting Linda G. Griffith, Massachusetts Institute of Technology Peter Gund, Gund Discovery Services Leroy Hood, Institute for Systems Biology Klaudyne Hong, Berlex Biosciences Joel R. Huff, Merck & Co., Inc. 44
OCR for page 45
APPENDIX D Randy Hungate, Amgen, Inc. Barbara Imperiali, Massachusetts Institute of Technology Gerald F. Joyce, Scripps Research Institute Stephen W. Kaldor, Syrrx, Inc. Sangtae Kim, Eli Lilly and Company Jack F. Kirsh, University of California, Berkeley William F. Koch, National Institute of Standards and Technology Walter Kozumbo, U.S. Air Force Office of Scientific Research Douglas A. Lauffenburger, Massachusetts Institute of Technology Ellen Leahy, Celera Genomics Thomas S. Leyh, Albert Einstein College of Medicine Craig E. Lunte, University of Kansas Sundar Madihally, Oklahoma State University Michael A. Marietta, University of California, Berkeley Luigi Marzilli, Louisiana State University Douglas D. McAbee, California State University, Long Beach Claude F. Meares, University of California, Davis Reginald Morales, University of Puerto Rico, Rio Piedras Thomas H. Morton, University of California, Riverside Larry E. Overman, University of California, Irvine Sean Palecek, University of Wisconsin, Madison C. Dale Poulter, University of Utah Paul J. Reider, Amgen, Inc. Dagmar Ringe, Brandeis University Michael E. Rogers, National Institute of General Medical Sciences W. Mark Saltzman, Yale University Christine E. Schmidt, University of Texas, Austin Peter G. Schultz, Scripps Research Institute John W. Scott, Bristol-Myers Squibb Michael L. Shuler, Cornell University Scott F. Singleton, Rice University Gregory Stephanopoulos, Massachusetts Institute of Technology Basil I. Swanson, Los Alamos National Laboratory James R. Swartz, Stanford University William C. Swope, IBM David H. Thompson, Purdue University Mathew Tirrell, University of California, Santa Barbara Ian A. Tomlinson, Dow Chemical Company Joan S. Valentine, University of California, Los Angeles Christopher T. Walsh, Harvard Medical School Mark K. Weise, Praxair, Inc. Chi-Huey Wong, Scripps Research Institute Michael Zaworotko, University of South Florida 45
Representative terms from entire chapter: